7-Methoxy-1-Tetralone CAS 6836-19-7 Munditia >99.0% (GC)
Ducens Manufacturer et supplementum Agomelatinae mediae
Agomelatine CAS 138112-76-2
7-Methoxy-1-Tetralone CAS 6836-19-7
7-Methoxy-1-Naphthaleneaceticum Acidum CAS 6836-22-2
7-Methoxy-1-Naphthylacetonitrile CAS 138113-08-3
7-Methoxy-1-Naphthaleneaceticum Acidum Ethyl Ester CAS 6836-21-1
Please contact: alvin@ruifuchem.com
| Nomen chemicum | 7-Methoxy-1-Tetralone |
| Synonyma | 3,4-Dihydro-7-Methoxy-1(2H)-Naphthalenone;7-Methoxy-3,4-Dihydro-2H-Naphthalen-1-unum;7-Methoxy-1-oxo-Tetralin;7-Methoxy-1,2,3,4-Tetrahydronaphthalene-1-unum;7-Methoxy-1-Oxotetraline;7-Methoxy-1-Tetralinone;7-Methoxytetralin-1-unum;Agomelatine medium B |
| CAS Number | 6836-19-7 |
| CATTUS Number | RF2689 |
| Stock Status | In Stock, Productio Capacity 30 Tons per Month |
| Formulae hypotheticae | C11H12O2 |
| M. Pondus | 176.22 |
| Liquescens punctum | 60.0 ad 64.0℃ |
| Density | 1.124±0.06 g/cm3 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Brown Crystal seu pulveris |
| Puritas / Analysis Methodus | >99.0% (GC) |
| Liquescens punctum | 60.0 ad 64.0℃ |
| Aqua (auctore Karl Fischer) | <0.50% |
| Residere in Ignition | <0.10% |
| una immunditia | <0.50% |
| Totalis immunditias | <1.00% |
| Infrared Imaginis | Conformat ut Structure |
| Proton NMR Spectrum | Conformat ut Structure |
| Test Standard | Enterprise Standard |
| Consuetudinem | Pharmaceutical Medium;Agomelatina (CAS 138112-76-2) Intermedia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
7-Methoxy-1-Tetraloneum (CAS: 6836-19-7) est medium Agomelatinum (CAS: 138112-76-2).Agomelatinum est antidepressum melatonergicum a pharmaceutico comitatu Servio elaboratum.Venale est ad curationem inordinationis depressivae maioris et relatum est ad syndromam discontinuationem non producendam et nullos effectus venereos respectu SSRIs, SNRIs et antidepressantium tricyclicorum vetustioribus.Agomelatina etiam effectus positivos in somno habere potest.1. Agomelatina pharmaceutica in tractatione deordinationis maioris depressivae, motus animi.2. Agomelatina adhibetur in curatione deordinationis maioris depressivae, motus inordinationis.Substantia medicata ad systema nervosum.Antidepressans, anxiolyticus, modulum somni componit et horologium biologicum moderans.3. Agomelatina est agonista melatoninergica et selectiva adversariorum receptorum 5-ht2c.4. Agomelatinum medicamentum antidepressans est.Indicatur ut disinhibitoris norepinephrine-dopamine (NDDI) ob eius repugnantiam receptoris 5-HT2C.5. Agomelatina est etiam potens agonista in receptoribus melatonini, quae efficit primum antidepressum melatonergicum.
